Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v2.4.0.8
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Cash flows from operating activities    
Net (loss) $ (18,704) $ (14,161)
Adjustments to reconcile net income/(loss) to net cash used in operating activities:    
Loss on disposal of discontinued operations, net of taxes 820  
Depreciation and amortization 1,856 646
Amortization of debt discount 187 1,420
Interest accrued 109 290
PIK Interest   151
Allowance for doubtful accounts   22
Finance costs 1,173  
Fair value of financing costs related to conversion options 470  
Stock-based compensation 1,938 487
Impairment of goodwill and intangibles 154 1,119
Issuance of common stock and warrants 406 555
Stock and stock options issued for services 2,755 3,079
Stock issued as settlement of debt with a supplier 24  
Settlement of debt with a supplier 51 (337)
Revaluation of contingent liability (603) (83)
Increase in fair value of derivative liabilities 811 22
Loss on disposal of leasehold improvements   41
Increase in restricted cash (200)  
(Increase) / decrease in assets:    
Accounts receivable (734) (260)
Deposits 523 (510)
Prepaid expenses and other current assets (2,566) 377
Increase / (decrease) in liabilities:    
Accounts payable (893) 513
Accrued license fees 737 (421)
Accrued compensation 650 110
Other liabilities and other items 3,229 75
Net cash used in operating activities (7,807) (6,865)
Cash flows from investing activities    
Purchase of property and equipment (207) (12)
Cash used in acquisition of subsidiary (1,287) (3,416)
Cash acquired with acquisition of subsidiary 513 59
Net cash used in investing activities (981) (3,369)
Cash flows from financing activities    
Repayment of debt obligations (3,657)  
Issuance of shares for cash 33,297 2,550
Net cash provided by financing activities 29,640 2,550
Effect of exchange rate changes on cash and cash equivalents (196) 34
Net change in cash and cash equivalents 20,656 (7,650)
Cash and cash equivalents, beginning of period 1,149 8,799
Cash and cash equivalents, end of period 21,805 1,149
Supplemental disclosure of cash flow information:    
Taxes paid 74 34
Supplemental disclosure of non-cash investing and financing activities:    
Conversion of convertible note and interest to shares of common stock 4,373  
Contingency earn out on acquisition of subsidiary, net of discount 238 841
Common stock of the Company issued for pending acquisition of an asset   533
Common stock of the Company issued for acquisition of subsidiary 4,449 788
Exercise of options to purchase common stock of the Company 854  
Exercise of warrants to purchase common stock of the Company $ 5,914 $ 474